Cite

HARVARD Citation

    Lewis, K. et al. (2021). Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience. British journal of haematology. pp. 1049-1053. [Online]. 
  
Back to record